Clinical Trials

The James Cancer Center Columbus, OH

open for enrollment

Ph Ib/II, Atezolizumab W Or W/O Bacille Calmette-Guérin In Pts W/ High-Risk Non−Muscleinvasive Bl

Protocol: OSU-16174

Full Title

A Phase Ib/II, Open-Label Study Of The Safety And Pharmacology Of Atezolizumab Administered With Or Without Bacille Calmette-Guérin In Patients With High-Risk Non−Muscleinvasive Bladder Cancer.